This guideline describes newborn screening laboratory tests for detecting analytes and genetic markers associated with cystic fibrosis (CF). It includes both the first-tier and second-tier screening tests performed on newborn dried blood spot specimens, as well as the screening strategies for identifying newborns at increased risk for developing CF.
More Standards PDF
CLSI X06R
$90.00 $180.00
CSA B125.1-05/ASME A112.18.1-05
$69.00 $139.00
CSA ANSI Z21.79a-2005 (R2021)/CGA 6.21a-2005 (R2021)
$52.00 $104.00
CSA B149 HB-05
$78.00 $156.00